Perception, Cognition, and Gait in Parkinson's Disease
Trial
N/A
Completed
Feb. 10, 2021
LRRK2 Activity and Markers of Parkinson's Disease in G2385R Carriers
Trial
N/A
Completed
Feb. 8, 2021
Cognitive Dysfunction in Parkinson's Disease
Trial
N/A
Completed
Feb. 8, 2021
Evaluation of a Multimodal Neuroimaging Method for Diagnosis in Parkinsonian Syndromes
Trial
N/A
Completed
Feb. 8, 2021
Exploration of the Mechanism of Movement Improvement During RBD in Parkinson's Disease Using NIRS
Trial
N/A
Completed
Feb. 8, 2021
Figure-of-Eight Walk Test in Parkinson
Trial
N/A
Unknown
Feb. 3, 2021
Neurophysiological Characteristics of Subthalamic Deep-brain Stimulation (STN-DBS)
Trial
N/A
Withdrawn
Feb. 2, 2021
Follow Up Safety Study of SCH 420814 in Subjects With Parkinson's Disease (P05175)
Trial
Phase 2
Completed
Feb. 1, 2021
Acupuncture for Anxiety in Parkinson's Disease
Trial
N/A
Unknown
Feb. 1, 2021
Utilization of Target Ranges to Treat Persons With Parkinson's Disease by Objective Measurement Using the PKG
Trial
N/A
Withdrawn
Jan. 31, 2021
Microbiota Modification for the Treatment of Motor Complication of Parkinson´s Disease
Trial
Phase 1
Completed
Jan. 28, 2021
Crossover Target Engagement Study of Cholinergic Mechanisms of Gait Dysfunction in Parkinson's Disease (Project #3 - Experiment 3 [UdallP3E3])
Trial
Phase 2
Completed
Jan. 26, 2021
Medication Responsiveness in Parkinson's Disease
Trial
Phase 2
Completed
Jan. 26, 2021
Non-invasive Neurostimulation in Parkinson's Disease
Trial
N/A
Completed
Jan. 26, 2021
Effect of Computer-based Cognitive Training on Attention and Executive Functions in Patients With Parkinson's Disease
Trial
N/A
Completed
Jan. 25, 2021
Orthostatic Dysregulation and Associated Gastrointestinal Dysfunction in Parkinson's Disease -Treatment
Trial
Phase 2
Completed
Jan. 24, 2021
Inhibiting COMT in Parkinson's Disease
Trial
N/A
Withdrawn
Jan. 24, 2021
Effects of Lactobacillus Plantarum PS128 on the Parkinsonian Symptoms in Parkinson's Disease.
Trial
N/A
Unknown
Jan. 24, 2021
Effects of Lactobacillus Plantarum PS128 on Symptoms of Early-onset Parkinson's Disease: a Pilot Study
Trial
N/A
Unknown
Jan. 24, 2021
Study of the Symptomatic Effects of Nocturnal Sodium Oxybate in Parkinson's Disease
Trial
Phase 2
Completed
Jan. 24, 2021